Predicting mammalian species at risk of being infected by SARS-CoV-2 from an ACE2 perspective | Scientific Reports
Frontiers | The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
Sequence difference of angiotensin-converting enzyme 2 between nonhuman primates affects its binding-affinity with SARS-CoV-2 S receptor binding domain | Biosafety and Health
Molecules in pathogenesis: angiotensin converting enzyme 2 (ACE2) | Journal of Clinical Pathology
Vaccines | Free Full-Text | S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review
ACE2 Nascence, trafficking, and SARS-CoV-2 pathogenesis: the saga continues | Human Genomics | Full Text
Characterization of Angiotensin-Converting Enzyme 2 Ectodomain Shedding from Mouse Proximal Tubular Cells | PLOS ONE
Comparative ACE2 variation and primate COVID-19 risk | Communications Biology
IJMS | Free Full-Text | Do Changes in ACE-2 Expression Affect SARS-CoV-2 Virulence and Related Complications: A Closer Look into Membrane-Bound and Soluble Forms
Frontiers | ACE2 Shedding and the Role in COVID-19
Discovery of human ACE2 variants with altered recognition by the SARS-CoV-2 spike protein | PLOS ONE
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding - ScienceDirect
Frontiers | Development of Plant-Produced Recombinant ACE2-Fc Fusion Protein as a Potential Therapeutic Agent Against SARS-CoV-2
In silico comparison of SARS-CoV-2 spike protein-ACE2 binding affinities across species and implications for virus origin | Scientific Reports
Mutations in the SARS-CoV-2 receptor-binding domain analyzed
Frontiers | Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?
Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions | PNAS
Comparative ACE2 variation and primate COVID-19 risk | bioRxiv
Frontiers | Can ACE2 Receptor Polymorphism Predict Species Susceptibility to SARS-CoV-2?
Coronavirus Sars-Cov-2 responsible for the COVID-19 pandemic is a specialist in infecting humans - SciELO in Perspective | Press Releases
Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine | Cellular & Molecular Immunology
N501Y mutation of spike protein in SARS-CoV-2 strengthens its binding to receptor ACE2 | eLife
Cells | Free Full-Text | Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2